Bimi International Medical Inc (BIMI) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Bimi International Medical Inc stock forecast from 0 analysts, the average analyst target price for Bimi International Medical Inc is not available over the next 12 months. Bimi International Medical Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bimi International Medical Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Bimi International Medical Inc’s stock price was USD 0.00. Bimi International Medical Inc’s stock price has changed by +0.00% over the past week, +100.00% over the past month and -99.98% over the last year.
No recent analyst target price found for Bimi International Medical Inc
No recent average analyst rating found for Bimi International Medical Inc
Company Overview Bimi International Medical Inc
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York. Read Less
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale...Read More
Frequently Asked Questions About Bimi International Medical Inc (BIMI) Stock
Stock Target Advisor's fundamental analysis for Bimi International Medical Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on BIMI's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BIMI's stock to indicate what its average analyst target is.
BIMI stock's Price/Earning ratio is 92.50.
Our analysis grades BIMI stock's Price / Earning ratio at D+. This means that BIMI stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Pharmaceutical Retailers sector in the NSD exchange.
Based on this BIMI may be fairly valued for its sector
The last closing price of BIMI's stock was USD 0.00.
The most recent market capitalization for BIMI is USD 1.40K.
Unfortunately we do not have enough analyst data on BIMI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Bimi International Medical Inc's stock.
As per our most recent records Bimi International Medical Inc has 296 Employees.
Bimi International Medical Inc's registered address is 725 5th Avenue, New York, NY, United States, 10022.
You can get more information about it from Bimi International Medical Inc's website at https://usbimi.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Bimi International Medical Inc (BIMI) Stock
Stock Target Advisor's fundamental analysis for Bimi International Medical Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on BIMI's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BIMI's stock to indicate what its average analyst target is.
BIMI stock's Price/Earning ratio is 92.50.
Our analysis grades BIMI stock's Price / Earning ratio at D+. This means that BIMI stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Pharmaceutical Retailers sector in the NSD exchange.
Based on this BIMI may be fairly valued for its sector
The last closing price of BIMI's stock was USD 0.00.
The most recent market capitalization for BIMI is USD 1.40K.
Unfortunately we do not have enough analyst data on BIMI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Bimi International Medical Inc's stock.
As per our most recent records Bimi International Medical Inc has 296 Employees.
Bimi International Medical Inc's registered address is 725 5th Avenue, New York, NY, United States, 10022.
You can get more information about it from Bimi International Medical Inc's website at https://usbimi.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BIMI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
